据中国之声《全球华语广播网》报道，近期，国家食品药品监督局决定今年8至12月在全国范围组织开展易制毒化学品专项整治行动。在这一背景下，北京、浙江、江西等多个省份陆续开始实行实名购买"麻黄碱复方制剂"的政策。

According to the sound of China[The global Chinese radio network]reports,recent,State food and drug supervision bureau decided this year 8 to 12 months in the national scope the organization carries out the precursor chemicals special improvement action.In this context,Beijing/zhejiang/Jiangxi provinces have began to implement real name to buy"Ephedrine compound preparation"policy.

　　生活中常用的"白加黑""新康泰克""日夜百服宁"等感冒药都属于含"麻黄碱成分的复方制剂"。这些药品中含有的微量麻黄碱成分，能够用于提炼、制造、合成毒品。

Life commonly used"White and black""Maytag new health""Bufferin day and night"Cold medicines such as belong to contain"Ephedrine components of compound preparation".These drugs contain trace ephedrine composition,Can be used to refine/manufacturing/Synthetic drugs.

　　"麻黄碱复方制剂"为什么需要实名购买呢？它里面究竟含有什么成分？据悉，1盒"新康泰克"胶囊可以提取伪麻黄碱约0.9克。在较高制作水平下，1克麻黄碱就可以提炼0.75克的冰毒。

"Ephedrine compound preparation"Why there is a need to buy real name?It actually contain what composition?It is reported,1 box"Maytag new health"Capsule can extract pseudoephedrine about 0.9 grams.In high production level,1 g ephedrine can refine 0.75 grams of methamphetamine.

　　据统计，全国20多个省、市、自治区曾破获涉麻黄碱类复方制剂犯罪案件，浙江、广东甚至出现垄断、走私"新康泰克"的案例。

According to the statistics,The national more than 20 provinces/city/Autonomous regions have unearthed in ephedrine kind of compound preparation crimes,zhejiang/Guangdong appear even monopoly/smuggling"Maytag new health"case.

　　事实上，限制"麻黄碱复方制剂"的购买，这种情况也曾在东南亚一些国家发生过。《人民日报》国际部副主任任彦曾在东南亚国家工作多年：

In fact,limit"Ephedrine compound preparation"purchase,This kind of situation has happened in southeast Asia countries.[People's Daily]International, deputy director of the RenYanCeng in southeast Asia countries for many years:

　　任彦：在泰国，有的商店要求不仅出示有效身份证件，而且还要签名。感冒药最多只能买三盒，在有些商店最多只能买两盒，一般来讲，药店里面有专门出售感冒药的柜台，把感冒药放到柜台的后面，作为顾客接触不到这个药物。

RenYan:In Thailand,Some stores require not only produce valid identity certificate,But also the signature.Cold medicine most can only buy three box,In some stores are most only can buy two boxes,Generally speaking,Pharmacy there are special sell the counter of cold medicine,The cold medicine on the back of the counter,As a customer contact less than the drug.

　　在法国，情况有所不同。生活在法国的万凌虹女士介绍，感冒药在法国属于处方药范畴，买药可以，但您得出示处方和医疗卡才行。

In France,Situation is different.Life in France WanLing rainbow lady is introduced,Cold medicines in France belong to the category of prescription drugs,Buy medicine can,But you will have to show prescription and declares to just go.

　　万凌虹：一般情况下，如果我们要去药店买药的话，必须要有医生的处方。如果没有处方的话很多药品是不能够卖的，是什么样的东西我们是可能不需要医生开处方的呢？跌打损伤药，像创可贴或者是说皮肤干燥润肤膏类的药品在药店买是不需要处方的，但其他都需要的。

WanLing rainbow:generally,If we want to went to a chemist's shop to buy medicine words,There must be a doctor's prescription.If there is no prescription words many drugs is not able to sell,What kind of things we are may not need a doctor prescribe?Damage medicine entitled,Like a band-aid or mean dry skin moisturizer kind of drug in the drug store to buy is not to need the prescription,But other needs.

　　美国对于药物的管理有着更严格的法律规定。《凤凰卫视》纽约记者庞哲：

The United States for drug management has a more strict laws and regulations.[Phoenix TV]New York reporter PangZhe:

　　庞哲：美国政府1970年通过药物生产发行进口使用的广泛控制法案，这个法案规定出5种不同的类型的药物和不同程度的管理，有两个联邦机构美国医药食品管理局和美国联邦毒品管理委员会，来选择和决定哪些药物成为被控制和监管的药物。这些药物类型的分割基本上根据功能和用途，例如医疗效用，人体适应程度、上瘾程度和伤害程度，以及国际控制药物的标准来决定。但是也会不断的进行调整，凡是被列上名单的药物病人就一定要在医生开出处方的情况下才可以得到，其他方式获得这种控制名单中的药物者都会受到法律惩处。

PangZhe:The United States government in 1970 through the drug production issue import used widely control act,The law out of five different types of drugs and different levels of management,There are two federal agencies American medicine food administration and the us federal drug administration committee,To choose and decide what drug be control and supervision of drugs.These drugs types of segmentation basically according to function and use,Such as medical utility,Human body adapt to the degree/Addictive degree and the degree of damage,And the international control drug standards to decide.But also continue to adjust,Those who be listed on the list of drugs patient must be under the open under the condition of prescription can get,The other way to get this kind of control list of drugs will be the legal punishment.

　　买感冒药也要登记个人身份信息，如何确保这些信息不被商家泄露？这是中国百姓目前最关注的问题。有法律专家认为，这项购药实名制的新规可能存在的最大隐患在于个人信息保护方面，药店需做好相应的保密和信息管理工作。因为目前我国对个人信息的保护还缺少一部量身订制的专门法律，可能致使不法分子、或不良商家的有机可乘。

Buy cold medicine to also want to registration personal identity information,How to ensure the information not by the businessman leak?This is the Chinese people the most attention.Has a legal experts say,The purchase system medicine new gauge the biggest possible hidden danger lies in the personal information protection,Pharmacy need to be done to the corresponding security and information management.At present in our country because of personal information protection is the lack of a custom-made special law,May the outlaws/Or undesirable businessman takes advantage of.

　　那么东南亚国家药品实名限购之初情况如何，老百姓买不买账？大家是否存在对于个人信息"外泄"的隐患？ 人民日报国际部副主任任彦：

So southeast Asia the national drug is restricted only at the beginning of the situation,People buy not buy it?Everyone whether there is for personal information"leaked"Hidden trouble? The People's Daily, deputy director of the international RenYan:

　　任彦：在东南亚一些国家有一些做的还是比较好的，药品的商店有一个非常完善的信息库，这个是跟当地司法部门联网的，绝对不能够出于商业目的或者其他的营业性目的泄漏消费者个人信息，如果发现有泄漏的话，要追究法律的责任。但是其他一些东南亚的国家这方面做的也不是很好，不时的有这种消费者的身份信息被泄漏出去，所以现在很多东南亚国家也在着手立法。

RenYan:In some southeast Asian countries, there are some do still better,Drug stores have a very perfect information base,This is with the local judicial department of networking,Absolute can't for commercial purposes or other commercial purpose leakage consumers' personal information,If you find any leakage words,Shall be investigated for legal responsibility.But some other southeast Asia countries do this also is not very good,Sometimes have this kind of consumer identity information is leak,So now, many Asian countries also embarking on legislation.

　　旅居法国的万凌虹女士说：在法国，虽然也没有所谓"个人信息保护"方面的单独立法，但是刑法中有着明确的规定，而且处罚一点不含糊。

Sojourn French WanLing rainbow woman says:In France,Although there is no"Personal information protection"Aspects of legislation alone,But in the criminal law has clear rules,And punishment a bit unambiguous.

　　万凌虹：他们应该也是会有担心，但是有时候这些担心是没有办法的，为什么？比方说上次我们家买了一个电视，像这项消费行为的话商家是一定会把你的信息给到税务局的，它这个不会帮你隐瞒的，它不会再泄漏给其他方面。法国对个人隐私还是有保护的。如果没有经过他本人同意把隐私信息泄漏出去，按照法国刑法会判处一年监禁和500欧元罚款，最高判处5年监禁和30万元的罚款，实际上还是有一定的威慑作用的。

WanLing rainbow:They should also there will be worried about,But sometimes these worry is that there is no way,why?For example the last time we bought a TV,Like the consumption behavior word merchants are will give your information to the tax bureau,It won't help you hide,It won't leak to the other aspects.The French to individual privacy or a protected.If without him I agree that the privacy information leak out,According to the criminal law in France will be sentenced to a year in jail and fined 500 euros,The highest sentenced to five years in prison and a $300000 fine,In fact there are still certain deterrent effect.

　　在美国，保险公司对商家有更多的约束，以此保证病人隐私不外泄。

In the United States,The insurance company to the businessman have more constraint,To guarantee the patient privacy not leaked.

　　庞哲：在个人隐私方面，一般保险公司会遵守合约，在没有病人的同意下，不会随意将病人的信息与其他商家分享。在病人就医时医生会在病人开始诊断之前签署书面协议，就是有关隐私资料是否与相关机构，例如药剂师、化验室等机构进行交流，要得到病人签字许可，而医生与病人之间的沟通也受法律保护的，不会对任何人和机构进行泄漏。司法机构也必须要在有法庭的命令之下才能获得病人的病情资料。

PangZhe:In the personal privacy aspects,General insurance company will abide by the contract,Without the consent of the patient,Not optional will the patient's information and other business share.In the patient when go to a doctor the doctor in the patient began to diagnosis before written agreement signed,Whether is about privacy information and relevant organizations,For example the pharmacist/Institutions such as laboratory to communicate,To get the patient signing licensing,And the communication between doctors and patients are protected by law,Not for anyone and institutions for leakage.The judiciary must also have the order of the court to get under the patient's condition material.